Copper metabolism in cell death and autophagy

References

• Chen J, Jiang Y, Shi H, et al. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflügers Archiv - European Journal of Physiology. 2020;472(10):1415–1429.
   PubMed Web of Science ®Google Scholar
• Steffens GC, Biewald R, Buse G. Cytochrome c oxidase is a three-copper, two-heme-A protein. Eur J Biochem. 1987;164(2):295–300.
   PubMedGoogle Scholar
• In: Harris ED. Copper as acofactor and regulator of copper,zinc superoxide dismutase. J Nutr1992Vol. 122pp. 636–640
   PubMed Web of Science ®Google Scholar
• Krishnamoorthy L, Cotruvo JA Jr., Chan J, et al. Copper regulates cyclic-AMP-dependent lipolysis. Nat Chem Biol. 2016;12(8):586–592. DOI:10.1038/nchembio.2098
   PubMed Web of Science ®Google Scholar
• Helman SL, Zhou J, Fuqua BK, et al. The biology of mammalian multi-copper ferroxidases. Biometals. 2022;36(2):263–281. DOI:10.1007/s10534-022-00370-z
   PubMed Web of Science ®Google Scholar
• Ash DE, Papadopoulos NJ, Colombo G, et al. Kinetic and spectroscopic studies of the interaction of copper with dopamine beta-hydroxylase. J Biol Chem. 1984;259(6):3395–3398.
   PubMed Web of Science ®Google Scholar
• Smith-Mungo LI, Kagan HM. Lysyl oxidase: properties, regulation and multiple functions in biology. Matrix Biol. 1998;16(7):387–398.
   PubMed Web of Science ®Google Scholar
• Brady DC, Crowe MS, Greenberg DN, et al. Copper Chelation Inhibits BRAF(V600E)-Driven Melanomagenesis and Counters Resistance to BRAF(V600E) and MEK1/2 Inhibitors. Cancer Res. 2017;77(22):6240–6252.
   PubMed Web of Science ®Google Scholar
• Tsang T, Posimo JM, Gudiel AA, et al. Copper is an essential regulator of the autophagic kinases ULK1/2 to drive lung adenocarcinoma. Nat Cell Biol. 2020;22(4):412–424.
   PubMed Web of Science ®Google Scholar
• Guo J, Cheng J, Zheng N, et al. Copper Promotes Tumorigenesis by Activating the PDK1-AKT Oncogenic Pathway in a Copper Transporter 1 Dependent Manner. Adv Sci (Weinh). 2021;8(18):1–14. DOI:10.1002/advs.202004303
   Google Scholar
• Hainaut P, Rolley N, Davies M, et al. Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene. 1995;10:27–32.
   PubMed Web of Science ®Google Scholar
• Klevay LM. Cardiovascular disease from copper deficiency–a history. J Nutr. 2000;130:489S–492S.
   PubMed Web of Science ®Google Scholar
• Myint ZW, Oo TH, Thein KZ, et al. Copper deficiency anemia: review article. Ann Hematol. 2018;97:1527–1534.
   PubMed Web of Science ®Google Scholar
• Strain JJ. A reassessment of diet and osteoporosis–possible role for copper. Med Hypotheses. 1988;27:333–338.
   PubMed Web of Science ®Google Scholar
• Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022; 7: p. 378.
   PubMed Web of Science ®Google Scholar
• Ala A, Walker AP, Ashkan K, et al. Wilson’s disease. Lancet. 2007;369:397–408.
   PubMed Web of Science ®Google Scholar
• Ejaz HW, Wang W, Lang M. Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches. Int J Mol Sci. 2020;21:7660.
   PubMed Web of Science ®Google Scholar
• Bremner I. Manifestations of copper excess. Am J Clin Nutr. 1998;67:1069S–1073S.
   PubMed Web of Science ®Google Scholar
• Ge EJ, Bush AI, Casini A, et al. Connecting copper and cancer: from transition metal signalling to metalloplasia. Nat Rev Cancer. 2022;22:102–113.
   PubMed Web of Science ®Google Scholar
• Ishida S, Andreux P, Poitry-Yamate C, et al. Bioavailable copper modulates oxidative phosphorylation and growth of tumors. Proc Natl Acad Sci U S A. 2013;110:19507–19512.
   PubMed Web of Science ®Google Scholar
• Cai H, Wu JS, Muzik O, et al. Reduced 64Cu uptake and tumor growth inhibition by knockdown of human copper transporter 1 in xenograft mouse model of prostate cancer. J Nucl Med. 2014;55:622–628.
   PubMed Web of Science ®Google Scholar
• Brady DC, Crowe MS, Turski ML, et al. Copper is required for oncogenic BRAF signalling and tumorigenesis. Nature. 2014;509:492–496.
   PubMed Web of Science ®Google Scholar
• Shanbhag V, Jasmer-McDonald K, Zhu S, et al. ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis. Proc Natl Acad Sci U S A. 2019;116:6836–6841.
   PubMed Web of Science ®Google Scholar
• Finney L, Vogt S, Fukai T, et al. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin Exp Pharmacol Physiol. 2009;36:88–94.
   PubMed Web of Science ®Google Scholar
• Pavithra V, Sathisha TG, Kasturi K, et al. Serum levels of metal ions in female patients with breast cancer. J Clin Diagn Res. 2015;9:BC25–c7.
   PubMedGoogle Scholar
• Feng JF, Lu L, Zeng P, et al. Serum total oxidant/antioxidant status and trace element levels in breast cancer patients. Int J Clin Oncol. 2012;17:575–583.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang Q. Association between serum copper levels and lung cancer risk: a meta-analysis. J Int Med Res. 2018;46:4863–4873.
   PubMed Web of Science ®Google Scholar
• Huhti E, Poukkula A, Uksila E. Serum copper levels in patients with lung cancer. Respiration. 1980;40:112–116.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Shukla VK, Vaidya MP, et al. Serum and tissue trace elements in colorectal cancer. J Surg Oncol. 1993;52:172–175.
   PubMed Web of Science ®Google Scholar
• Lopez J, Ramchandani D, Vahdat L. Copper Depletion as a Therapeutic Strategy in Cancer. Met Ions Life Sci. 2019;19:303–330.
   Google Scholar
• da Silva DA, De Luca A, Squitti R, et al. Copper in tumors and the use of copper-based compounds in cancer treatment. J Inorg Biochem. 2022;226:111634.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Berghe TV, et al. The molecular machinery of regulated cell death. Cell Res. 2019;29:347–364.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, et al.Guidelines for the use and interpretation of assays for monitoring autophagy 4th Autophagy. 2021;17:1–382.
   Google Scholar
• Song IS, Chen HH, Aiba I, et al. Transcription factor Sp1 plays an important role in the regulation of copper homeostasis in mammalian cells. Mol Pharmacol. 2008;74:705–713.
   PubMed Web of Science ®Google Scholar
• Petris MJ, Smith K, Lee J, et al. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J Biol Chem. 2003;278:9639–9646.
   PubMed Web of Science ®Google Scholar
• PMo MA, Mura CV, Nu´n˜ez MT. DMT1, a physiologically relevant apical Cu1+ transporter of intestinal cells. Am J Physiol Cell Physiol. 2003;284:1525–1530.
   Web of Science ®Google Scholar
• Wong DW PC, Subramaniam JR, Tessarollo L, et al. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. PNAS. 1999;97:2886–2891.
   Web of Science ®Google Scholar
• Wang X, Zhang H, Sapio R, et al. SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer. Nat Commun. 2021;12:2259.
   PubMed Web of Science ®Google Scholar
• Gomez ML, Shah N, Kenny TC, et al. SOD1 is essential for oncogene-driven mammary tumor formation but dispensable for normal development and proliferation. Oncogene. 2019;38:5751–5765.
   PubMed Web of Science ®Google Scholar
• Tsang CK, Chen M, Cheng X, et al. SOD1 Phosphorylation by mTORC1 Couples Nutrient Sensing and Redox Regulation. Mol Cell. 2018;70:502–15 e8.
   PubMed Web of Science ®Google Scholar
• Sturtz KD LA, Jensen LT. Roland Lill and Valeria Cizewski Culotta. A fraction of yeast Cu/Zn superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria: a physiological role for SOD1 in guarding against mitochondrial oxidative damage. J Biol Chem. 2001;276:38084–38089.
   PubMed Web of Science ®Google Scholar
• Cobine PA, Pierrel F, Winge DR. Copper trafficking to the mitochondrion and assembly of copper metalloenzymes. Biochim Biophys Acta. 2006;1763:759–772.
   PubMed Web of Science ®Google Scholar
• Timon-Gomez A, Nyvltova E, Abriata LA, et al. Mitochondrial cytochrome c oxidase biogenesis: recent developments. Semin Cell Dev Biol. 2018;76:163–178.
   PubMed Web of Science ®Google Scholar
• Bedi M, Ray M, Ghosh A. Active mitochondrial respiration in cancer: a target for the drug. Mol Cell Biochem. 2022;477:345–361.
   PubMed Web of Science ®Google Scholar
• Suzuki C, Daigo Y, Kikuchi T, et al. Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res. 2003;63:7038–7041.
   PubMed Web of Science ®Google Scholar
• Singh RP, Jeyaraju DV, Voisin V, et al. Disrupting Mitochondrial Copper Distribution Inhibits Leukemic Stem Cell Self-Renewal. Cell Stem Cell. 2020;26:926–37 e10.
   PubMed Web of Science ®Google Scholar
• Iqbal Hamza AF, Prohaska J, Chen J, et al. The metallochaperone Atox1 plays a critical role in perinatal copper homeostasis. Proceedings of the National Academy of Sciences. 2001;98:6848–6852.
   PubMed Web of Science ®Google Scholar
• Zhang X, Walke GR, Horvath I, et al. Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro. Proceedings of the National Academy of Sciences. 2022;119:e2206905119.
   PubMed Web of Science ®Google Scholar
• Polishchuk EV, Concilli M, Iacobacci S, et al. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev Cell. 2014;29:686–700.
   PubMed Web of Science ®Google Scholar
• P WSN. Atp7A-Regulated enzyme metalation and trafficking in the menkes disease puzzle. Biomedicines. 2021;9:391.
   PubMed Web of Science ®Google Scholar
• Jin J, Ma M, Shi S, et al. Copper enhances genotoxic drug resistance via ATOX1 activated DNA damage repair. Cancer Lett. 2022;536:215651.
   PubMed Web of Science ®Google Scholar
• Blockhuys S, Zhang X, Wittung-Stafshede P. Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration. Proc Natl Acad Sci U S A. 2020;117:2014–2019.
   PubMed Web of Science ®Google Scholar
• Blockhuys S, Wittung-Stafshede P. Copper chaperone Atox1 plays role in breast cancer cell migration. Biochem Biophys Res Commun. 2017;483:301–304.
   PubMed Web of Science ®Google Scholar
• Feng W, Ye F, Xue W, et al. Copper regulation of hypoxia-inducible factor-1 activity. Mol Pharmacol. 2009;75:174–182.
   PubMed Web of Science ®Google Scholar
• Beaino W, Guo Y, Chang AJ, et al. Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy. J Biol Inorg Chem. 2014;19:427–438.
   PubMed Web of Science ®Google Scholar
• Itoh S, Kim HW, Nakagawa O, et al. Novel role of antioxidant-1 (Atox1) as a copper-dependent transcription factor involved in cell proliferation. J Biol Chem. 2008;283:9157–9167.
   PubMed Web of Science ®Google Scholar
• Wang J, Luo C, Shan C, et al. Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation. Nat Chem. 2015;7:968–979.
   PubMed Web of Science ®Google Scholar
• Inkol JM, Poon AC, Mutsaers AJ. Inhibition of copper chaperones sensitizes human and canine osteosarcoma cells to carboplatin chemotherapy. Vet Comp Oncol. 2020;18:559–569.
   PubMed Web of Science ®Google Scholar
• Li Y, Liang R, Zhang X, et al. Copper chaperone for superoxide dismutase promotes breast cancer cell proliferation and migration via ROS-Mediated MAPK/ERK Signaling. Front Pharmacol. 2019;10:356.
   PubMed Web of Science ®Google Scholar
• Ding F, Li F, Tang D, et al. Restoration of the immunogenicity of tumor cells for enhanced cancer therapy via nanoparticle-mediated copper chaperone inhibition. Angew Chem Int Ed Engl. 2022;61:e202203546.
   PubMed Web of Science ®Google Scholar
• Attar N, Campos OA, Vogelauer M, et al. The histone H3-H4 tetramer is a copper reductase enzyme. Science. 2020;369:59–64.
   PubMed Web of Science ®Google Scholar
• Juarez-Rebollar D, Rios C, Nava-Ruiz C, et al. Metallothionein in Brain Disorders. Oxid Med Cell Longev. 2017;2017:5828056.
   PubMed Web of Science ®Google Scholar
• Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11:107.
   PubMed Web of Science ®Google Scholar
• Freedman MRC JH, Peisach J. The role of glutathione in copper metabolism and toxicity. J Biol Chem. 1989;264:5598–5605.
   PubMed Web of Science ®Google Scholar
• Lu H, Samanta D, Xiang L, et al. Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype. Proc Natl Acad Sci U S A. 2015;112:E4600–9.
   PubMed Web of Science ®Google Scholar
• La Fontaine S, Mercer JF. Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis. Arch Biochem Biophys. 2007;463:149–167.
   PubMed Web of Science ®Google Scholar
• Fieten H, Gill Y, Martin AJ, et al. The Menkes and Wilson disease genes counteract in copper toxicosis in Labrador retrievers: a new canine model for copper-metabolism disorders. Dis Model Mech. 2016;9:25–38.
   PubMed Web of Science ®Google Scholar
• Li Y. Copper homeostasis: emerging target for cancer treatment. IUBMB Life. 2020;72:1900–1908.
   PubMed Web of Science ®Google Scholar
• Aubert L, Nandagopal N, Steinhart Z, et al. Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nat Commun. 2020;11:3701.
   PubMed Web of Science ®Google Scholar
• Lukanovic D, Herzog M, Kobal B, et al. The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancer. Biomed Pharmacother. 2020;129:110401.
   PubMed Web of Science ®Google Scholar
• Yatim N, Cullen S, Albert ML. Dying cells actively regulate adaptive immune responses. Nat Rev Immunol. 2017;17:262–275.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Buque A, Kepp O, et al. Immunogenic cell death in cancer and infectious disease. Nat Rev Immunol. 2017;17:97–111.
   PubMed Web of Science ®Google Scholar
• Shi Y. Mechanisms of Caspase Activation and Inhibition during Apoptosis. Molecular Cell. 2002;9:459–470.
   PubMed Web of Science ®Google Scholar
• Locksley NK RM, Lenardo MJ. The TNF and TNF Receptor Superfamilies: integrating Mammalian Biology. Cell. 2001;104. p. 487–501.
   PubMed Web of Science ®Google Scholar
• Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996;86:147–157.
   PubMed Web of Science ®Google Scholar
• Wang Y, An R, Umanah GK, et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science. 2016;354:aad6872.
   PubMed Web of Science ®Google Scholar
• Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99–104.
   PubMed Web of Science ®Google Scholar
• Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol. 2008;9:47–59.
   PubMed Web of Science ®Google Scholar
• Westphal D, Kluck RM, Dewson G. Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis. Cell Death Differ. 2014;21:196–205.
   PubMed Web of Science ®Google Scholar
• Giuseppa Pistritto DT, Ceci C, Garufi A, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603–619.
   PubMedGoogle Scholar
• Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481–490.
   PubMed Web of Science ®Google Scholar
• Sutton HC, Winterbourn CC. On the participation of higher oxidation states of iron and copper in Fenton reactions. Free Radic Biol Med. 1989;6:53–60.
   PubMed Web of Science ®Google Scholar
• Kawakami M, Inagawa R, Hosokawa T, et al. Mechanism of apoptosis induced by copper in PC12 cells. Food Chem Toxicol. 2008;46:2157–2164.
   PubMed Web of Science ®Google Scholar
• Ozcelik D, Ozaras R, Gurel Z, et al. Copper-mediated oxidative stress in rat liver. Biol Trace Elem Res. 2003;96:209–215.
   PubMed Web of Science ®Google Scholar
• Sagripanti JL, Goering PL, Lamanna A. Interaction of copper with DNA and antagonism by other metals. Toxicol Appl Pharmacol. 1991;110:477–485.
   PubMed Web of Science ®Google Scholar
• Zimmer C, Luck G, Fritzsche H, et al. DNA-copper (II) complex and the DNA conformation. Biopolymers. 1971;10:441–463.
   PubMed Web of Science ®Google Scholar
• Tkeshelashvili TM LK, Spence K, Loeb LA. Mutation Spectrum of Copper-induced DNA Damage. J Biol Chem. 1991;266:6401–6406.
   PubMed Web of Science ®Google Scholar
• Chen X, Dou QP, Liu J, et al. Targeting Ubiquitin-Proteasome System with Copper Complexes for Cancer Therapy. Front Mol Biosci. 2021;8:649151.
   PubMed Web of Science ®Google Scholar
• Chen D, Cui QC, Yang H, et al. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 2006;66:10425–10433.
   PubMed Web of Science ®Google Scholar
• Liu N, Liu C, Li X, et al. A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases. Sci Rep. 2014;4:5240.
   PubMed Web of Science ®Google Scholar
• Arakawa H. P53, apoptosis and axon-guidance molecules. Cell Death Differ. 2005;12:1057–1065.
   PubMed Web of Science ®Google Scholar
• KH V. P53: death Star. Cell. 2000;103:691–694.
   PubMed Web of Science ®Google Scholar
• Ostrakhovitch EA, Cherian MG. Role of p53 and reactive oxygen species in apoptotic response to copper and zinc in epithelial breast cancer cells. Apoptosis. 2005;10:111–121.
   PubMed Web of Science ®Google Scholar
• Chen CH, Chou YT, Yang YW, et al. High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines. Apoptosis. 2021;26:612–627.
   PubMed Web of Science ®Google Scholar
• Liao Y, Zhao J, Bulek K, et al. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis. Nat Commun. 2020;11:900.
   PubMed Web of Science ®Google Scholar
• Jiang X, Wang J, Deng X, et al. Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape. Mol Cancer. 2019;18:10.
   PubMed Web of Science ®Google Scholar
• Voli F, Valli E, Lerra L, et al. Intratumoral Copper Modulates PD-L1 Expression and Influences Tumor Immune Evasion. Cancer Res. 2020;80:4129–4144.
   PubMed Web of Science ®Google Scholar
• Sperandio IdB S, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. PNAS. 2000;97:14376–14381.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wen X, Zhang N, et al. Small-molecule compounds target paraptosis to improve cancer therapy. Biomed Pharmacother. 2019;118:109203.
   PubMed Web of Science ®Google Scholar
• Kim E, Lee DM, Seo MJ, et al. Intracellular Ca(2 +) Imbalance Critically Contributes to Paraptosis. Front Cell Dev Biol. 2020;8:607844.
   PubMed Web of Science ®Google Scholar
• Gandin V, Pellei M, Tisato F, et al. A novel copper complex induces paraptosis in colon cancer cells via the activation of ER stress signalling. J Cell Mol Med. 2012;16:142–151.
   PubMed Web of Science ®Google Scholar
• Kim IY, Shim MJ, Lee DM, et al. Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death. Biochem Pharmacol. 2019;162:41–54.
   PubMed Web of Science ®Google Scholar
• Dilshara MG, Neelaka Molagoda IM, Tharanga Jayasooriya RG P, et al. Indirubin-3’-monoxime induces paraptosis in MDA-MB-231 breast cancer cells by transmitting Ca(2+) from endoplasmic reticulum to mitochondria. Arch Biochem Biophys. 2021;698:108723.
   PubMed Web of Science ®Google Scholar
• Wei W, Li Y, Wang C, et al. Diterpenoid Vinigrol specifically activates ATF4/DDIT3-mediated PERK arm of unfolded protein response to drive non-apoptotic death of breast cancer cells. Pharmacol Res. 2022;182:106285.
   PubMed Web of Science ®Google Scholar
• Yoon MJ, Kang YJ, Lee JA, et al. Stronger proteasomal inhibition and higher CHOP induction are responsible for more effective induction of paraptosis by dimethoxycurcumin than curcumin. Cell Death Dis. 2014;5:e1112.
   PubMed Web of Science ®Google Scholar
• Chen X, Chen X, Zhang X, et al. Curcuminoid B63 induces ROS-mediated paraptosis-like cell death by targeting TrxR1 in gastric cells. Redox Biol. 2019;21:101061.
   PubMed Web of Science ®Google Scholar
• Raimondi M, Fontana F, Marzagalli M, et al. Ca(2+) overload- and ROS-associated mitochondrial dysfunction contributes to delta-tocotrienol-mediated paraptosis in melanoma cells. Apoptosis. 2021;26:277–292.
   PubMed Web of Science ®Google Scholar
• Sperandio S, Poksay K, de Belle I, et al. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ. 2004;11:1066–1075.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang F, Yang Y, et al. Paraptosis-Inducing Nanomedicine Overcomes Cancer Drug Resistance for a Potent Cancer Therapy. Small. 2018;14:1–12.
   Web of Science ®Google Scholar
• Li GN, Zhao XJ, Wang Z. Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation, et al. Signal Transduct Target Ther. 2022;7:317.
   PubMed Web of Science ®Google Scholar
• Tardito S, Bassanetti I, Bignardi C, et al. Copper binding agents acting as copper ionophores lead to caspase inhibition and paraptotic cell death in human cancer cells. J Am Chem Soc. 2011;133:6235–6242.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang X, Chen J, et al. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells. Eur J Pharmacol. 2017;815:147–155.
   PubMed Web of Science ®Google Scholar
• Tardito S, Isella C, Medico E, et al. The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009;284:24306–24319.
   PubMed Web of Science ®Google Scholar
• Barilli A, Atzeri C, Bassanetti I, et al. Oxidative stress induced by copper and iron complexes with 8-hydroxyquinoline derivatives causes paraptotic death of HeLa cancer cells. Mol Pharm. 2014;11:1151–1163.
   PubMedGoogle Scholar
• Kovacs SB, EA M. Gasdermins: effectors of Pyroptosis. Trends Cell Biol. 2017;27:673–684.
   PubMed Web of Science ®Google Scholar
• Wu R, Wang N, Comish PB, et al. Inflammasome-Dependent Coagulation Activation in Sepsis. Front Immunol. 2021;12:641750.
   PubMed Web of Science ®Google Scholar
• Zou J, Zheng Y, Huang Y, et al. The Versatile Gasdermin Family: their Function and Roles in Diseases. Front Immunol. 2021;12:751533.
   PubMed Web of Science ®Google Scholar
• Zhang H, Zeng L, Xie M, et al. TMEM173 Drives Lethal Coagulation in Sepsis. Cell Host Microbe. 2020;27:556–70.e6.
   PubMed Web of Science ®Google Scholar
• Tang D, Wang H, Billiar TR, et al. Emerging mechanisms of immunocoagulation in sepsis and septic shock. Trends Immunol. 2021;42:508–522.
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6:128.
   PubMed Web of Science ®Google Scholar
• Guo R, Wang H, Cui N. Autophagy Regulation on Pyroptosis: mechanism and Medical Implication in Sepsis. Mediators Inflamm. 2021;2021:9925059.
   PubMed Web of Science ®Google Scholar
• Vande Walle L, Lamkanfi M. Pyroptosis. Curr Biol. 2016;26:R568–72.
   PubMed Web of Science ®Google Scholar
• Chen R, Zeng L, Zhu S, et al. cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis. Sci Adv. 2019;5:eaav5562.
   PubMed Web of Science ®Google Scholar
• Kang R, Zeng L, Zhu S, et al. Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. Cell Host Microbe. 2018;24:97–108 e4.
   PubMed Web of Science ®Google Scholar
• Liao J, Yang F, Tang Z, et al. Inhibition of Caspase-1-dependent pyroptosis attenuates copper-induced apoptosis in chicken hepatocytes. Ecotoxicol Environ Saf. 2019;174:110–119.
   PubMed Web of Science ®Google Scholar
• Liao J, Hu Z, Li Q, et al. Endoplasmic Reticulum Stress Contributes to Copper-Induced Pyroptosis via Regulating the IRE1alpha-XBP1 Pathway in Pig Jejunal Epithelial Cells. J Agric Food Chem. 2022;70:1293–1303.
   PubMed Web of Science ®Google Scholar
• Tang D, Kroemer G. Ferroptosis. Curr Biol. 2020;30:R1–6.
   PubMed Web of Science ®Google Scholar
• Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280–296.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107–125.
   PubMed Web of Science ®Google Scholar
• Chen X, Li J, Kang R, et al. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054–2081.
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599–620.
   PubMed Web of Science ®Google Scholar
• Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317–331.
   PubMed Web of Science ®Google Scholar
• Yang WS, Kim KJ, Gaschler MM, et al. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci U S A. 2016;113:E4966–75.
   PubMed Web of Science ®Google Scholar
• Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91–98.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81–90.
   PubMed Web of Science ®Google Scholar
• Yuan H, Li X, Zhang X, et al. Identification of ACSL4 as a biomarker and contributor of ferroptosis. Biochem Biophys Res Commun. 2016;478:1338–1343.
   PubMed Web of Science ®Google Scholar
• Lin Z, Liu J, Long F, et al. The lipid flippase SLC47A1 blocks metabolic vulnerability to ferroptosis. Nat Commun. 2022;13:7965.
   PubMed Web of Science ®Google Scholar
• Yan B, Ai Y, Sun Q, et al. Membrane Damage during Ferroptosis is Caused by Oxidation of Phospholipids Catalyzed by the Oxidoreductases POR and CYB5R1. Mol Cell. 2021;81:355–369.
   PubMed Web of Science ®Google Scholar
• Zou Y, Li H, Graham ET, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302–309.
   PubMed Web of Science ®Google Scholar
• Kuang F, Liu J, Xie Y, et al. MGST1 is a redox-sensitive repressor of ferroptosis in pancreatic cancer cells. Cell Chem Biol. 2021;28:765–75.e5.
   PubMed Web of Science ®Google Scholar
• Sun X, Ou Z, Chen R, et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 2016;63:173–184.
   PubMed Web of Science ®Google Scholar
• Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693–698.
   PubMed Web of Science ®Google Scholar
• Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688–692.
   PubMed Web of Science ®Google Scholar
• Dai E, Zhang W, Cong D, et al. AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochem Biophys Res Commun. 2020;523:966–971.
   PubMed Web of Science ®Google Scholar
• Liu J, Kang R, Tang D. Signaling pathways and defense mechanisms of ferroptosis. FEBS J. 2021;289:7038–7050.
   PubMed Web of Science ®Google Scholar
• Kuang F, Liu J, Tang D, et al. Oxidative Damage and Antioxidant Defense in Ferroptosis. Front Cell Dev Biol. 2020;8:586578.
   PubMed Web of Science ®Google Scholar
• Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–1072.
   PubMed Web of Science ®Google Scholar
• Ren X, Li Y, Zhou Y, et al. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis. Redox Biol. 2021;46:102122.
   PubMed Web of Science ®Google Scholar
• Gao W, Huang Z, Duan J, et al. Elesclomol induces copper-dependent ferroptosis in colorectal cancer cells via degradation of ATP7A. Mol Oncol. 2021;15:3527–3544.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen F, Chen J, et al. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways. Cancers (Basel). 2020;12:138.
   PubMed Web of Science ®Google Scholar
• Belyaeva EA, Sokolova TV, Emelyanova LV, et al. Mitochondrial electron transport chain in heavy metal-induced neurotoxicity: effects of cadmium, mercury, and copper. ScientificWorldjournal. 2012;2012:136063.
   PubMedGoogle Scholar
• Xue Q, Yan D, Chen X, et al. Copper-dependent autophagic degradation of GPX4 drives ferroptosis. Autophagy. 2023;1–15.
   PubMed Web of Science ®Google Scholar
• Zhou H, Liu Z, Zhang Z, et al. Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis. Bioact Mater. 2023;24:322–330.
   PubMed Web of Science ®Google Scholar
• Martin F, Linden T, Katschinski DM, et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood. 2005;105:4613–4619.
   PubMed Web of Science ®Google Scholar
• Yang M, Chen P, Liu J, et al. Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv. 2019;5:eaaw2238.
   PubMed Web of Science ®Google Scholar
• Yang M, Wu X, Hu J, et al. COMMD10 inhibits HIF1alpha/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma. J Hepatol. 2022;5:1138–1150.
   Google Scholar
• Xiong J, Nie M, Fu C, et al. Hypoxia Enhances HIF1alpha Transcription Activity by Upregulating KDM4A and Mediating H3K9me3, Thus Inducing Ferroptosis Resistance in Cervical Cancer Cells. Stem Cells Int. 2022;2022:1608806.
   PubMed Web of Science ®Google Scholar
• Li F, Wu X, Liu H, et al. Copper Depletion Strongly Enhances Ferroptosis via Mitochondrial Perturbation and Reduction in Antioxidative Mechanisms. Antioxidants (Basel). 2022;11:2084.
   PubMedGoogle Scholar
• Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375:1254–1261.
   PubMed Web of Science ®Google Scholar
• Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32:417–418.
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu SY, Zeng L, et al. An Enzyme-Engineered Nonporous Copper(I) Coordination Polymer Nanoplatform for Cuproptosis-Based Synergistic Cancer Therapy. Adv Mater. 2022;34:e2204733.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Wnag Y, et al. HMGB1 is a mediator of cuproptosis-related sterile inflammation. Front Cell Dev Biol. 2022;10:996307.
   PubMed Web of Science ®Google Scholar
• Tsvetkov P, Detappe A, Cai K, et al. Mitochondrial metabolism promotes adaptation to proteotoxic stress. Nat Chem Biol. 2019;15:681–689.
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Biological Functions of Autophagy Genes: a Disease Perspective. Cell. 2019;176:11–42.
   PubMed Web of Science ®Google Scholar
• Xie Y, Kang R, Sun X, et al. Posttranslational modification of autophagy-related proteins in macroautophagy. Autophagy. 2015;11:28–45.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011;13:132–141.
   PubMed Web of Science ®Google Scholar
• Zhao M, Klionsky DJ. AMPK-dependent phosphorylation of ULK1 induces autophagy. Cell Metab. 2011;13:119–120.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang W, Sun X, et al. AMPK regulates autophagy by phosphorylating BECN1 at threonine 388. Autophagy. 2016;12:1447–1459.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim YC, Fang C, et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell. 2013;152:290–303.
   PubMed Web of Science ®Google Scholar
• Wirawan E, Vanden Berghe T, Lippens S, et al. Autophagy: for better or for worse. Cell Res. 2012;22:43–61.
   PubMed Web of Science ®Google Scholar
• Russell RC, Tian Y, Yuan H, et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol. 2013;15:741–750.
   PubMed Web of Science ®Google Scholar
• Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer. 2020;19:12.
   PubMed Web of Science ®Google Scholar
• FRaPc PB. Emerging regulation and functions of autophagy. Nat Cell Biol. 2013;15:713–720.
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330:1344–1348.
   PubMed Web of Science ®Google Scholar
• Russell RC, Guan KL. The multifaceted role of autophagy in cancer. Embo J. 2022;41:e110031.
   PubMed Web of Science ®Google Scholar
• Li J, Chen X, Kang R, et al. Regulation and function of autophagy in pancreatic cancer. Autophagy. 2021;17:3275–3296.
   PubMed Web of Science ®Google Scholar
• Denton D, Kumar S. Autophagy-dependent cell death. Cell Death Differ. 2019;26:605–616.
   PubMed Web of Science ®Google Scholar
• Liu J, Kuang F, Kroemer G, et al. Autophagy-Dependent Ferroptosis: machinery and Regulation. Cell Chem Biol. 2020;27:420–435.
   PubMed Web of Science ®Google Scholar
• Chen X, Yu C, Kang R, et al. Cellular degradation systems in ferroptosis. Cell Death Differ. 2021;28:1135–1148.
   PubMed Web of Science ®Google Scholar
• Hou W, Xie Y, Song X, et al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425–1428.
   PubMed Web of Science ®Google Scholar
• Gao M, Monian P, Pan Q, et al. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26:1021–1032.
   PubMed Web of Science ®Google Scholar
• Bai Y, Meng L, Han L, et al. Lipid storage and lipophagy regulates ferroptosis. Biochem Biophys Res Commun. 2019;508:997–1003.
   PubMed Web of Science ®Google Scholar
• Wu Z, Geng Y, Lu X, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proc Natl Acad Sci U S A. 2019;116:2996–3005.
   PubMed Web of Science ®Google Scholar
• Zhou B, Liu J, Kang R, et al. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89–100.
   PubMed Web of Science ®Google Scholar
• Han L, Bai L, Fang X, et al. SMG9 drives ferroptosis by directly inhibiting GPX4 degradation. Biochem Biophys Res Commun. 2021;567:92–98.
   PubMed Web of Science ®Google Scholar
• Chen X, Song X, Li J, et al. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy 2022:1–21.
   Google Scholar
• Liu K, Huang J, Liu J, et al. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022;13:521.
   PubMed Web of Science ®Google Scholar
• Li J, Liu J, Xu Y, et al. Tumor heterogeneity in autophagy-dependent ferroptosis. Autophagy. 2021;17:3361–3374.
   PubMed Web of Science ®Google Scholar
• Liu J, Liu Y, Wang Y, et al. TMEM164 is a new determinant of autophagy-dependent ferroptosis. Autophagy. 2022;1–12.
   Google Scholar
• Wan F, Zhong G, Ning Z, et al. Long-term exposure to copper induces autophagy and apoptosis through oxidative stress in rat kidneys. Ecotoxicol Environ Saf. 2020;190:110158.
   PubMed Web of Science ®Google Scholar
• Guo H, Ouyang Y, Yin H, et al. Induction of autophagy via the ROS-dependent AMPK-Mtor pathway protects copper-induced spermatogenesis disorder. Redox Biol. 2022;49:102227.
   PubMed Web of Science ®Google Scholar
• Shi J, Zhao Y, Wang Y, et al. Inflammatory caspases are innate immune receptors for intracellular LPS. Nature. 2014;514:187–192.
   PubMed Web of Science ®Google Scholar
• Polishchuk EV, Merolla A, Lichtmannegger J, et al. Activation of Autophagy, Observed in Liver Tissues from Patients with Wilson Disease and from ATP7B-Deficient Animals, Protects Hepatocytes from Copper-Induced Apoptosis. Gastroenterology. 2019;156:1173–89 e5.
   PubMed Web of Science ®Google Scholar
• Pena KA, Kiselyov K. Transition metals activate TFEB in overexpressing cells. Biochem J. 2015;470:65–76.
   PubMed Web of Science ®Google Scholar
• Yu Z, Zhou R, Zhao Y, et al. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death. Cell Prolif. 2019;52:1–11.
   Web of Science ®Google Scholar
• Luo Q, Song Y, Kang J, et al. mtROS-mediated Akt/AMPK/mTOR pathway was involved in Copper-induced autophagy and it attenuates Copper-induced apoptosis in RAW264.7 mouse monocytes. Redox Biol. 2021;41:101912.
   PubMed Web of Science ®Google Scholar
• Laha D, Pramanik A, Maity J, et al. Interplay between autophagy and apoptosis mediated by copper oxide nanoparticles in human breast cancer cells MCF7. Biochim Biophys Acta. 2014;1840:1–9.
   PubMed Web of Science ®Google Scholar
• Wu X, Xue X, Wang L, et al. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer. Eur J Pharmacol. 2018;827:1–12.
   PubMed Web of Science ®Google Scholar
• Sun T, Yan Y, Zhao Y, et al. Copper oxide nanoparticles induce autophagic cell death in A549 cells. PLoS ONE. 2012;7:e43442.
   PubMed Web of Science ®Google Scholar
• Guo WJ, Ye SS, Cao N, et al. ROS-mediated autophagy was involved in cancer cell death induced by novel copper(II) complex. Exp Toxicol Pathol. 2010;62:577–582.
   PubMedGoogle Scholar
• Nandanwar SK, aHJ K. Anticancer and Antibacterial Activity of Transition Metal Complexes. ChemistrySelect. 2019;4:1706–1721.
   Web of Science ®Google Scholar
• Denoyer D, Clatworthy SAS, Cater MA. Copper Complexes in Cancer Therapy. Met Ions Life Sci. 2018;18:469–506.
   Google Scholar
• Mohindru A, Fisher JM, Rabinovitz M. 2, 9-Dimethyl-1, 10-phenanthroline (neocuproine): a potent, copper-dependent cytotoxin with anti-tumor activity. Biochem Pharmacol. 1983;32:3627–3632.
   PubMed Web of Science ®Google Scholar
• Park KC, Fouani L, Jansson PJ, et al. Copper and conquer: copper complexes of di-2-pyridylketone thiosemicarbazones as novel anti-cancer therapeutics. Metallomics. 2016;8:874–886.
   PubMed Web of Science ®Google Scholar
• Lovejoy DB, Jansson PJ, Brunk UT, et al. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes. Cancer Res. 2011;71:5871–5880.
   PubMed Web of Science ®Google Scholar
• Gupte A, Mumper RJ. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells. Free Radic Biol Med. 2007;43:1271–1278.
   PubMed Web of Science ®Google Scholar
• Qiao S, Cabello CM, Lamore SD, et al. D-Penicillamine targets metastatic melanoma cells with induction of the unfolded protein response (UPR) and Noxa (PMAIP1)-dependent mitochondrial apoptosis. Apoptosis. 2012;17:1079–1094.
   PubMed Web of Science ®Google Scholar
• Sciegienka SJ, Solst SR, Falls KC, et al. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H(2)O(2)-mediated oxidative stress. Free Radic Biol Med. 2017;108:354–361.
   PubMed Web of Science ®Google Scholar
• Yoshida D, Ikeda Y, Nakazawa S. Suppression of 9L gliosarcoma growth by copper depletion with copper-deficient diet and D-penicillamine. J Neurooncol. 1993;17:91–97.
   PubMed Web of Science ®Google Scholar
• Fatfat M, Merhi RA, Rahal O, et al. Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC Cancer. 2014;14:527.
   PubMed Web of Science ®Google Scholar
• Yoshii J, Yoshiji H, Kuriyama S, et al. The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells. Int J Cancer. 2001;94:768–773.
   PubMed Web of Science ®Google Scholar
• Liu YL, Bager CL, Willumsen N, et al. Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer. NPJ Breast Cancer. 2021;7:108.
   PubMed Web of Science ®Google Scholar
• Li Y, Fang M, Xu Z, et al. Tetrathiomolybdate as an old drug in a new use: as a chemotherapeutic sensitizer for non-small cell lung cancer. J Inorg Biochem. 2022;233:111865.
   PubMed Web of Science ®Google Scholar
• Xu M, Casio M, Range DE, et al. Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer. Clin Cancer Res. 2018;24:4271–4281.
   PubMed Web of Science ®Google Scholar
• Baldari S, Di Rocco G, Heffern MC, et al. Effects of Copper Chelation on BRAF(V600E) Positive Colon Carcinoma Cells. Cancers (Basel). 2019;11:1–17.
   Web of Science ®Google Scholar
• Khan G, Merajver S. Copper chelation in cancer therapy using tetrathiomolybdate: an evolving paradigm. Expert Opin Investig Drugs. 2009;18:541–548.
   PubMed Web of Science ®Google Scholar
• Ramchandani D, Berisa M, Tavarez DA, et al. Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun. 2021;12:7311.
   PubMed Web of Science ®Google Scholar
• Brewer GJ. The use of copper-lowering therapy with tetrathiomolybdate in medicine. Drug Eval. 2009;18:89–97.
   Google Scholar
• Juarez JC, Betancourt O Jr., Pirie-Shepherd SR, et al. Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1. Clin Cancer Res. 2006;12:4974–4982.
   PubMed Web of Science ®Google Scholar
• Hassouneh B, Islam M, Nagel T, et al. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Mol Cancer Ther. 2007;6:1039–1045.
   PubMed Web of Science ®Google Scholar
• Kumar P, Yadav A, Patel SN, et al. Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Mol Cancer. 2010;9:206.
   PubMed Web of Science ®Google Scholar
• Lee K, Briehl MM, Mazar AP, et al. The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies. Free Radic Biol Med. 2013;60:157–167.
   PubMed Web of Science ®Google Scholar
• Pan Q, Bao LW, Merajver SD. Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade. Mol Cancer Res. 2003;1:701–706.
   PubMed Web of Science ®Google Scholar
• Pan Q, Kleer CG, van Golen KL, et al. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Res. 2002;62:4854–4859.
   PubMed Web of Science ®Google Scholar
• Kim KK, Kawar NM, Singh RK, et al. Tetrathiomolybdate induces doxorubicin sensitivity in resistant tumor cell lines. Gynecol Oncol. 2011;122:183–189.
   PubMed Web of Science ®Google Scholar
• Koto KS, Lescault P, Brard L, et al. Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma. Int J Oncol. 2011;38:1329–1341.
   PubMed Web of Science ®Google Scholar
• Chisholm CL, HWAH-HWGV-OWCXXC-XD. Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin. Oncotarget 2016; 7: 84439–84452.
   PubMedGoogle Scholar
• Chen SJ, Kuo CC, Pan HY, et al. Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo. Biochem Pharmacol. 2015;95:28–37.
   PubMed Web of Science ®Google Scholar
• Zhang J, Duan D, Xu J, et al. Redox-Dependent Copper Carrier Promotes Cellular Copper Uptake and Oxidative Stress-Mediated Apoptosis of Cancer Cells. ACS Appl Mater Interfaces. 2018;10:33010–33021.
   PubMed Web of Science ®Google Scholar
• Bao XZ, Dai F, Li XR, et al. Targeting redox vulnerability of cancer cells by prooxidative intervention of a glutathione-activated Cu(II) pro-ionophore: hitting three birds with one stone. Free Radic Biol Med. 2018;124:342–352.
   PubMed Web of Science ®Google Scholar
• Yu H, Zhou Y, Lind SE, et al. Clioquinol targets zinc to lysosomes in human cancer cells. Biochem J. 2009;417:133–139.
   PubMed Web of Science ®Google Scholar
• Tardito S, Barilli A, Bassanetti I, et al. Copper-dependent cytotoxicity of 8-hydroxyquinoline derivatives correlates with their hydrophobicity and does not require caspase activation. J Med Chem. 2012;55:10448–10459.
   PubMed Web of Science ®Google Scholar
• Zhai S, Yang L, Cui QC, et al. Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells. J Biol Inorg Chem. 2010;15:259–269.
   PubMed Web of Science ®Google Scholar
• Cao B, Li J, Zhu J, et al. The antiparasitic clioquinol induces apoptosis in leukemia and myeloma cells by inhibiting histone deacetylase activity. J Biol Chem. 2013;288:34181–34189.
   PubMed Web of Science ®Google Scholar
• Cater MA, Haupt Y. Clioquinol induces cytoplasmic clearance of the X-linked inhibitor of apoptosis protein (XIAP): therapeutic indication for prostate cancer. Biochem J. 2011;436:481–491.
   PubMed Web of Science ®Google Scholar
• Katsuyama M, Kimura E, Ibi M, et al. Clioquinol inhibits dopamine-beta-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells. Arch Toxicol. 2021;95:135–148.
   PubMed Web of Science ®Google Scholar
• Kannappan V, Ali M, Small B, et al. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents. Front Mol Biosci. 2021;8:741316.
   PubMed Web of Science ®Google Scholar
• Skrott Z, Mistrik M, Andersen KK, et al. Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4. Nature. 2017;552:194–199.
   PubMed Web of Science ®Google Scholar
• Liu P, Brown S, Goktug T, et al. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells. Br J Cancer. 2012;107:1488–1497.
   PubMed Web of Science ®Google Scholar
• Liu X, Wang L, Cui W, et al. Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells. Oncotarget. 2016;7:58516–58528.
   PubMedGoogle Scholar
• Guo F, Yang Z, Kulbe H, et al. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation. Biomed Pharmacother. 2019;118:109371.
   PubMed Web of Science ®Google Scholar
• Read E, Milford J, Zhu J, et al. The interaction of disulfiram and H2S metabolism in inhibition of aldehyde dehydrogenase activity and liver cancer cell growth. Toxicol Appl Pharmacol. 2021;426:115642.
   PubMed Web of Science ®Google Scholar
• Alli E, Ford JM. Breast cancers with compromised DNA repair exhibit selective sensitivity to elesclomol. DNA Repair (Amst). 2012;11:522–524.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wang J, Sim MS, et al. Elesclomol, counteracted by Akt survival signaling, enhances the apoptotic effect of chemotherapy drugs in breast cancer cells. Breast Cancer Res Treat. 2010;121:311–321.
   PubMed Web of Science ®Google Scholar
• Gohil VM. Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders. Expert Opin Investig Drugs. 2020;30:1–4.
   PubMed Web of Science ®Google Scholar
• Yadav AA, Patel D, Wu X, et al. Molecular mechanisms of the biological activity of the anticancer drug elesclomol and its complexes with Cu(II. Ni(ii) and Pt(ii) J Inorg Biochem. 2013;126:1–6.
   PubMed Web of Science ®Google Scholar
• Chen HY, Cheng WP, Chiang YF, et al. Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE). Int J Mol Sci. 2021;22:1–15.
   Web of Science ®Google Scholar
• Daniel KG, Chen D, Orlu S, et al. Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells. Breast Cancer Res. 2005;7:R897–908.
   PubMed Web of Science ®Google Scholar
• Chen J, Du C, Kang J, et al. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. Chem Biol Interact. 2008;171:26–36.
   PubMed Web of Science ®Google Scholar
• Ji Y, Dai F, Zhou B. Designing salicylaldehyde isonicotinoyl hydrazones as Cu(II) ionophores with tunable chelation and release of copper for hitting redox Achilles heel of cancer cells. Free Radic Biol Med. 2018;129:215–226.
   PubMed Web of Science ®Google Scholar
• Scrivner O, Dao L, Newell-Rogers MK, et al. The ionophore thiomaltol induces rapid lysosomal accumulation of copper and apoptosis in melanoma. Metallomics. 2021;14:mfab074.
   Web of Science ®Google Scholar
• Han J, Liu L, Yue X, et al. A binuclear complex constituted by diethyldithiocarbamate and copper(I) functions as a proteasome activity inhibitor in pancreatic cancer cultures and xenografts. Toxicol Appl Pharmacol. 2013;273:477–483.
   PubMed Web of Science ®Google Scholar
• Yip NC, Fombon IS, Liu P, et al. Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer. 2011;104:1564–1574.
   PubMed Web of Science ®Google Scholar
• Qiu C, Zhang X, Huang B, et al. Disulfiram, a Ferroptosis Inducer, Triggers Lysosomal Membrane Permeabilization by Up-Regulating ROS in Glioblastoma. Onco Targets Ther. 2020;13:10631–10640.
   PubMed Web of Science ®Google Scholar
• Alharbi FF, el-Guebaly N. The Relative Safety of Disulfiram. Addictive Disorders & Their Treatment. 2013;12:140–147.
   Google Scholar
• Cao B, Li J, Zhou X, et al. Clioquinol induces pro-death autophagy in leukemia and myeloma cells by disrupting the mTOR signaling pathway. Sci Rep. 2014;4:5749.
   PubMed Web of Science ®Google Scholar
• Leong C, Wang J, Toi MJ, et al. Effect of zinc pyrithione shampoo treatment on skin commensal Malassezia. Med Mycol. 2021;59:210–213.
   PubMed Web of Science ®Google Scholar
• Guthrie LM, Soma S, Yuan S, et al. Elesclomol alleviates Menkes pathology and mortality by escorting Cu to cuproenzymes in mice. Science. 2020;368:620–625.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang J, Zhang Q, et al. Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma. Oncogene. 2022;41:3539–3553.
   PubMed Web of Science ®Google Scholar
• Nagai M, Vo NH, Shin Ogawa L, et al. The oncology drug elesclomol selectively transports copper to the mitochondria to induce oxidative stress in cancer cells. Free Radic Biol Med. 2012;52:2142–2150.
   PubMed Web of Science ®Google Scholar
• Hanahan D. Hallmarks of Cancer: new Dimensions. Cancer Discov. 2022;12:31–46.
   PubMed Web of Science ®Google Scholar
• Chen X, Zeh HJ, Kang R, et al. Cell death in pancreatic cancer: from pathogenesis to therapy. Nat Rev Gastroenterol Hepatol. 2021;18:804–823.
   PubMed Web of Science ®Google Scholar